| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine, Medical College of Georgia, Augusta Georgia, United States
2 Medicine, Medical College of Georgia, Augusta, Georgia, United States
* To whom correspondence should be addressed. E-mail: gsupinski{at}mail.mcg.edu.
Loss of functional capacity of skeletal muscle is a major cause of morbidity in patients with a number of acute and chronic clinical disorders, including sepsis, COPD, heart failure, uremia and cancer. Weakness in these patients can manifest as either severe limb muscle weakness (even to the point of virtual paralysis), respiratory muscle weakness requiring mechanical ventilatory support and/or some combination of these phenomena. While factors such as nutritional deficiency and disuse may contribute to the development of muscle weakness in these conditions, systemic inflammation may be the major factor producing skeletal muscle dysfunction in these disorders. Importantly, studies conducted over the past 15 years indicate that free radical species (superoxide, hydroxyl radicals, nitric oxide, peroxynitrite, and the free radical derived product hydrogen peroxide) play an key role in modulating inflammation/infection induced alterations in skeletal muscle function. Substantial evidence exists indicating that several free radical species can directly alter contractile protein function, and evidence suggests that free radicals also have important effects on sarcoplasmic reticulum function, on mitochondrial function, and on sarcolemmal integrity. Free radicals also modulate activation of several proteolytic pathways, including proteosomally mediated protein degradation and, at least theoretically, may also influence pathways of protein synthesis. As a result, free radicals appear to play an important role in regulating a number of downstream processes that collectively act to impair muscle function and lead to reductions in muscle strength and mass in inflammatory conditions.
This article has been cited by other articles:
|
|
 |
|
  V. Dufresne, C. Knoop, A. Van Muylem, A. Malfroot, M. Lamotte, C. Opdekamp, G. Deboeck, M. Cassart, B. Stallenberg, G. Casimir, et al. Effect of Systemic Inflammation on Inspiratory and Limb Muscle Strength and Bulk in Cystic Fibrosis Am. J. Respir. Crit. Care Med., July 15, 2009; 180(2): 153 - 158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. S. Supinski, J. Vanags, and L. A. Callahan Effect of proteasome inhibitors on endotoxin-induced diaphragm dysfunction Am J Physiol Lung Cell Mol Physiol, June 1, 2009; 296(6): L994 - L1001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Barnes and B. R. Celli Systemic manifestations and comorbidities of COPD Eur. Respir. J., May 1, 2009; 33(5): 1165 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Huey, G. Fiscus, A. F. Richwine, R. W. Johnson, and B. M. Meador In vivo vitamin E administration attenuates interleukin-6 and interleukin-1{beta} responses to an acute inflammatory insult in mouse skeletal and cardiac muscle Exp Physiol, December 1, 2008; 93(12): 1263 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Powers and M. J. Jackson Exercise-Induced Oxidative Stress: Cellular Mechanisms and Impact on Muscle Force Production Physiol Rev, October 1, 2008; 88(4): 1243 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Lecarpentier Physiological role of free radicals in skeletal muscles J Appl Physiol, December 1, 2007; 103(6): 1917 - 1918. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. McClung, A. N. Kavazis, M. A. Whidden, K. C. DeRuisseau, D. J. Falk, D. S. Criswell, and S. K. Powers Antioxidant administration attenuates mechanical ventilation-induced rat diaphragm muscle atrophy independent of protein kinase B (PKB Akt) signalling J. Physiol., November 15, 2007; 585(1): 203 - 215. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
